{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T04:00:40Z","timestamp":1778817640512,"version":"3.51.4"},"reference-count":0,"publisher":"Portico","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1358\/dot.2019.55.1.2895651","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T06:00:53Z","timestamp":1548914453000},"page":"25","source":"Crossref","is-referenced-by-count":23,"title":["Ibalizumab for the treatment of multidrug-resistant HIV-1 infection"],"prefix":"10.3730","volume":"55","author":[{"family":"Rizza, S.A.","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Bhatia, R.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Zeuli, J.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Temesgen, Z.","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1320","published-online":{"date-parts":[[2019]]},"container-title":["Drugs of Today"],"original-title":[],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:36:04Z","timestamp":1685453764000},"score":1,"resource":{"primary":{"URL":"http:\/\/access.portico.org\/stable?au=pjbf7ddm44r"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":0,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1358\/dot.2019.55.1.2895651","relation":{},"ISSN":["1699-4019"],"issn-type":[{"value":"1699-4019","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]}}}